Echo Health Ventures

Echo Health Ventures is a venture capital firm that invests in healthcare companies, health technology, insurance technology and digital health in the United States. Based in Seattle with offices in Durham and Portland, the firm is stage-agnostic and aims to accelerate healthcare innovations to scale nationally by offering strategic guidance in addition to capital. Echo Health Ventures focuses on building deep, high-value relationships with portfolio companies to support growth and clinical impact, partnering with startups to advance patient care, improve care delivery, and broaden access to digital health tools.

Troy Arnold

Managing Principal, Echo Health Advisors

Karim Botros

Managing Partner, Strategic Investment

Lindsey Brown

Senior Associate, Strategic Investment

Robert Dolan

Managing Principal, Echo Health Advisors

Jon Eide

Managing Partner and COO

Ryan Gillooly

Principal

David Goad

Senior Associate, Strategic Investment

Jose Guerola

Principal, Strategic Investment

Matt Holman

Principal, Market Developement

Dusty Lieb

Partner

Maura Little

Managing Principal

Suzanne McLemore

Managing Partner and Head of Echo Health Advisors

Anahita Nakhjiri

Associate

Matt Parmett

Principal

Kurt Sheline

Principal

Anisha Sood

Partner

Annie Weissbach

Senior Associate, Strategic Investment

Jessica A. Zeaske

Partner

Pia Shivdasani Ph.D

Associate Principal, Echo Health Advisors

53 past transactions

Vori Health

Series B in 2025
Vori Health offers an integrated medical practice specializing in treating musculoskeletal conditions. Its nationwide, evidence-based approach addresses back, neck, and joint issues through a unique, virtual-first care model. Patients are connected to a collaborative team consisting of a board-certified physician, health coach navigator, and physical therapist for comprehensive care.

Thyme Care

Series C in 2024
Thyme Care is a healthcare company specializing in oncology care management services. It offers an integrated solution for patients and providers, partnering with health plans to deliver comprehensive, personalized support to cancer patients.

Heartbeat Health

Series C in 2024
Heartbeat Health, Inc. is a healthcare technology company based in New York that specializes in cardiology services. Founded in 2017, it provides virtual-first solutions for the prevention and management of cardiovascular disease. The company utilizes a data-powered platform to facilitate real-time consultations between patients and physicians, enabling secure communication and collaboration on treatment and dietary advice. By offering tools that allow patients to monitor their heart health, Heartbeat Health aims to reduce cardiovascular risk and the likelihood of adverse health events. Its comprehensive approach enhances patient care and supports at-risk organizations through a focus on higher-value healthcare delivery.

Thyme Care

Venture Round in 2024
Thyme Care is a healthcare company specializing in oncology care management services. It offers an integrated solution for patients and providers, partnering with health plans to deliver comprehensive, personalized support to cancer patients.

Eleanor Health

Venture Round in 2024
Eleanor Health is a provider of addiction and mental health services focused on delivering long-term recovery outcomes through a value-based care model. Founded in 2019 and headquartered in Waltham, Massachusetts, Eleanor offers comprehensive, whole-person care for mental health and substance misuse. The company operates a network of outpatient clinics and also provides virtual care as well as support in patients' homes and communities. Its services include medication-assisted treatment, evidence-based outpatient care, behavioral health services, and personalized recovery plans, all aimed at facilitating a faster recovery process for individuals suffering from substance abuse disorder.

Sempre Health

Venture Round in 2023
Sempre Health, Inc. is a healthcare technology company that operates a behavior-based healthcare pricing platform aimed at making prescription medications more affordable for patients. Founded in 2015 and based in San Francisco, the company collaborates with health plans and pharmaceutical manufacturers to dynamically adjust patients' co-payments based on their adherence to prescribed medications. By analyzing prescription records and individual patient behaviors, Sempre Health predicts the optimal price for medications at the point of sale. Patients receive personalized SMS notifications detailing potential discounts and guidance on improving their health, thereby encouraging timely prescription refills. This innovative approach not only enhances patient access to necessary medications but also contributes to better clinical outcomes while reducing overall healthcare costs. Additionally, Sempre Health is building a unique dataset on patient price sensitivities and cost behaviors to further refine its services.

Octave

Series B in 2023
Octave is a clinical platform developer focused on transforming the care landscape for multiple sclerosis and other neurodegenerative diseases. The company creates a platform that generates, analyzes, and integrates data to improve patient outcomes and reduce overall healthcare costs. By optimizing medication usage and healthcare services, Octave aims to enhance the efficiency of the pharmaceutical industry throughout the entire lifecycle of drug development, which includes discovery, clinical trials, and post-marketing phases. Their approach utilizes real-world evidence to inform decision-making, ultimately striving to set a new standard in multiple sclerosis care.

Strive Health

Series C in 2023
Strive Health, LLC is a company focused on providing comprehensive solutions for chronic kidney disease. Founded in 2018 and based in Denver, Colorado, Strive Health operates dialysis centers and employs advanced predictive analytics to enhance patient care. The company offers a high-touch, technology-enabled clinical model that supports patients throughout their healthcare journey, from primary care engagement to dialysis treatment. By utilizing comparative and predictive data, Strive Health aims to identify at-risk patients and transform the management of kidney disease, promoting earlier intervention and increasing the adoption of home dialysis. This innovative approach not only improves patient outcomes but also seeks to reduce inpatient utilization, ultimately enhancing the overall experience for individuals dealing with chronic kidney conditions.

Cortica

Series D in 2023
Cortica Inc. is a company dedicated to providing neurological therapies for children facing autism and other neurodevelopmental challenges. Founded in 2014 and based in San Diego, California, Cortica offers tailored treatment programs that are informed by a comprehensive understanding of each child's neurobiology and developmental profile. The company operates multiple centers across California, including locations in Carlsbad, Irvine, San Rafael, Torrance, and Westlake Village. Cortica's services encompass a wide range of assessments and therapies, including diagnoses for autism, ADHD, and developmental delays. Treatment options available include gene sequencing, metabolic testing, electroencephalography, nutrition evaluation, medication management, and various therapeutic interventions such as ABA therapy, parent coaching, speech-language therapy, occupational therapy, physical therapy, and music therapy. The company provides these services through in-home, in-clinic, and telehealth modalities.

Medix Infusion

Series B in 2023
Medix Infusion, Inc. is a healthcare provider specializing in ambulatory and home infusion therapy services for patients with chronic and acute conditions. Incorporated in 2020 and based in Arlington, Texas, the company operates multiple locations across the state. Medix Infusion offers a range of pharmacy services, including the placement of PICC lines, and administration of anti-infectives, IV antibiotics, anti-fungals, biologics, specialty injectables, total parenteral nutrition (TPN), and hydration therapy. The company is committed to enhancing patient care by delivering personalized and convenient infusion therapy, catering to the needs of high-acuity patients in rural, suburban, and underserved markets.

DispatchHealth

Venture Round in 2022
DispatchHealth Management, LLC is a provider of on-demand mobile and virtual healthcare services, founded in 2013 and headquartered in Denver, Colorado. The company offers a wide range of services, including evaluation and treatment for acute injuries and illnesses, laceration repair, splinting of injured extremities, and management of conditions like nosebleeds and catheter placements. It also facilitates medication administration, laboratory testing, outpatient imaging arrangements, and coordination with primary care physicians and home health agencies. By delivering care directly to patients in their homes or workplaces, DispatchHealth aims to enhance the capabilities of existing care teams while providing high-quality, cost-effective healthcare solutions.

Upfront Healthcare Services

Series C in 2022
Upfront Healthcare Services, Inc. is a Chicago-based company that specializes in creating a data analytics platform aimed at enhancing the ambulatory care experience for patients and healthcare providers. Founded in 2015, the company focuses on automating and personalizing care navigation to improve patient engagement and optimize resource allocation within physician practices. Its platform, known as Care Traffic Control, utilizes advanced analytics and personalized content to guide patients to the most appropriate care options, thereby increasing appointment efficiency and improving clinical outcomes. By leveraging a variety of data sources—including demographics, billing, scheduling, claims, and care gaps—Upfront Healthcare Services ensures that patient needs are effectively matched with available healthcare resources.

Abacus Insights

Series C in 2022
Abacus Insights, established in 2017 with headquarters in New York City and an additional office in Boston, specializes in developing a cloud-based data integration platform tailored for healthcare companies. This platform organizes and exchanges data from diverse sources and formats, offering maintenance and support services to clients. By standardizing data across the healthcare ecosystem through a secure unified infrastructure, Abacus Insights enables healthcare providers to generate actionable insights, enhance member outcomes, and lower care costs.

Waltz Health

Series A in 2022
Waltz Health is a company focused on innovating the pharmaceutical supply chain by developing technology-driven solutions for pricing, distribution, and prescription of medications. It collaborates with various partners, including consumers, payers, and pharmacies, to create smarter ways to manage prescription care. The company utilizes AI-driven marketplaces to reduce costs and offers consumer tools that enhance decision-making regarding healthcare. These tools provide users with better pricing, comprehensive information, and resources aimed at lowering expenses, empowering consumers, and enabling payers to effectively manage their pharmacy benefits. Through these efforts, Waltz Health strives to improve the overall experience and affordability of prescription medications.

Embold Health

Series B in 2022
Embold Health, Inc. is a healthcare analytics company based in Nashville, Tennessee, founded in 2017. The company specializes in analyzing de-identified medical data to evaluate the performance of healthcare providers, including doctors and hospitals. By assessing the quality and cost of care, Embold Health aims to enhance patient outcomes and empower employers, health plans, and consumers to identify and select top-performing providers. Its online search platform, accessible on both mobile and desktop, facilitates users in navigating medical research and clinical guidelines, ultimately streamlining the process of choosing appropriate healthcare services.

Wildflower Health

Venture Round in 2022
Founded in 2012, Wildflower Health is a San Francisco-based company that specializes in smartphone-based health programs. It offers Due Date Plus for maternity care and GROW for family health, providing services such as reminders, provider look-up, and health risk assessments to support users and connect them with healthcare providers.

Scipher Medicine

Series D in 2022
Scipher Medicine Corporation is a biotechnology company based in Waltham, Massachusetts, that specializes in precision medicine for patients with autoimmune and cardiovascular diseases. The company has developed a molecular technology platform that utilizes blood samples to analyze RNA and predict patient responses to drug therapies. Its primary offerings include PrismDx tests, which identify patients who may not respond to certain medications, ensuring they can be prescribed alternative treatments. Notably, the PrismRA test assesses patients with rheumatoid arthritis to determine their likelihood of responding to anti-TNF therapies, while PrismUC serves a similar purpose for patients with ulcerative colitis. By focusing on the underlying disease biology rather than just symptoms, Scipher Medicine aims to optimize treatment from the outset, potentially reducing the healthcare costs associated with ineffective therapies. Established in 2013 and rebranded in 2015, Scipher Medicine is committed to transforming drug prescription practices and advancing drug development through its innovative approach.

mPulse Mobile

Venture Round in 2022
mPulse Mobile, Inc. is a healthcare technology company based in Encino, California, specializing in communication solutions designed to enhance consumer health and wellness. The company offers mPulse, a cloud-based intelligent mobile messaging platform that features pre-configured workflows to address various healthcare challenges, including missed appointments, medication adherence, and disease management. Their solutions encompass a wide range of areas such as medication adherence, preventive care and screenings, chronic condition management, and optimization of health plan experiences. By leveraging conversational AI and analytics, mPulse Mobile aims to empower healthcare organizations to engage effectively with their customers, encouraging the adoption of healthier behaviors. Founded in 2014, the company serves diverse sectors, including Medicare, Medicaid, commercial plans, health systems, and wellness initiatives.

Genome Medical

Series C in 2021
Genome Medical operates a platform that connects individuals and healthcare providers with genetic specialists. It offers virtual genetic care services, including clinical consultations for various health areas like cancer, cardiology, and reproductive health. The company uses its Genome Care Delivery technology to facilitate efficient genetic assessments and personalized treatment plans.

Vori Health

Series A in 2021
Vori Health offers an integrated medical practice specializing in treating musculoskeletal conditions. Its nationwide, evidence-based approach addresses back, neck, and joint issues through a unique, virtual-first care model. Patients are connected to a collaborative team consisting of a board-certified physician, health coach navigator, and physical therapist for comprehensive care.

Main Street Health

Funding Round in 2021
Main Street Health delivers value-based, care-focused healthcare services addressing rural wellness challenges. It uses data-driven solutions to support partner clinics by providing staff, technology, and access to critical access hospitals and community health centers, enabling rural residents to receive high-quality treatment.

Eleanor Health

Series B in 2021
Eleanor Health is a provider of addiction and mental health services focused on delivering long-term recovery outcomes through a value-based care model. Founded in 2019 and headquartered in Waltham, Massachusetts, Eleanor offers comprehensive, whole-person care for mental health and substance misuse. The company operates a network of outpatient clinics and also provides virtual care as well as support in patients' homes and communities. Its services include medication-assisted treatment, evidence-based outpatient care, behavioral health services, and personalized recovery plans, all aimed at facilitating a faster recovery process for individuals suffering from substance abuse disorder.

Heartbeat Health

Series B in 2021
Heartbeat Health, Inc. is a healthcare technology company based in New York that specializes in cardiology services. Founded in 2017, it provides virtual-first solutions for the prevention and management of cardiovascular disease. The company utilizes a data-powered platform to facilitate real-time consultations between patients and physicians, enabling secure communication and collaboration on treatment and dietary advice. By offering tools that allow patients to monitor their heart health, Heartbeat Health aims to reduce cardiovascular risk and the likelihood of adverse health events. Its comprehensive approach enhances patient care and supports at-risk organizations through a focus on higher-value healthcare delivery.

Ideon

Series B in 2021
Ideon develops a healthcare data platform for the employee benefits sector. Its suite of application programming interfaces provides the infrastructure, or middleware, to help insurance and digital health companies access flows of data, creating modern digital experiences throughout the employee benefits ecosystem.

Cityblock

Series C in 2021
Cityblock Health, Inc., established in 2017 and headquartered in Brooklyn, New York, operates a personalized health system tailored to meet the unmet health and social needs of Medicaid and Medicare populations. The company's online platform offers integrated primary care, behavioral health, and virtual care services, along with a tool called Commons for communication, information sharing, and task management. Cityblock's model focuses on upstream investment in highly personalized, prevention-oriented care, aiming to improve outcomes and reduce costs. It partners with community-based organizations to deliver care, enabling clinicians to provide personalized care for each member. During the COVID-19 pandemic, Cityblock developed a model to help identify high-risk members within organizations.

Scipher Medicine

Series C in 2021
Scipher Medicine Corporation is a biotechnology company based in Waltham, Massachusetts, that specializes in precision medicine for patients with autoimmune and cardiovascular diseases. The company has developed a molecular technology platform that utilizes blood samples to analyze RNA and predict patient responses to drug therapies. Its primary offerings include PrismDx tests, which identify patients who may not respond to certain medications, ensuring they can be prescribed alternative treatments. Notably, the PrismRA test assesses patients with rheumatoid arthritis to determine their likelihood of responding to anti-TNF therapies, while PrismUC serves a similar purpose for patients with ulcerative colitis. By focusing on the underlying disease biology rather than just symptoms, Scipher Medicine aims to optimize treatment from the outset, potentially reducing the healthcare costs associated with ineffective therapies. Established in 2013 and rebranded in 2015, Scipher Medicine is committed to transforming drug prescription practices and advancing drug development through its innovative approach.

Strive Health

Series B in 2021
Strive Health, LLC is a company focused on providing comprehensive solutions for chronic kidney disease. Founded in 2018 and based in Denver, Colorado, Strive Health operates dialysis centers and employs advanced predictive analytics to enhance patient care. The company offers a high-touch, technology-enabled clinical model that supports patients throughout their healthcare journey, from primary care engagement to dialysis treatment. By utilizing comparative and predictive data, Strive Health aims to identify at-risk patients and transform the management of kidney disease, promoting earlier intervention and increasing the adoption of home dialysis. This innovative approach not only improves patient outcomes but also seeks to reduce inpatient utilization, ultimately enhancing the overall experience for individuals dealing with chronic kidney conditions.

DispatchHealth

Series D in 2021
DispatchHealth Management, LLC is a provider of on-demand mobile and virtual healthcare services, founded in 2013 and headquartered in Denver, Colorado. The company offers a wide range of services, including evaluation and treatment for acute injuries and illnesses, laceration repair, splinting of injured extremities, and management of conditions like nosebleeds and catheter placements. It also facilitates medication administration, laboratory testing, outpatient imaging arrangements, and coordination with primary care physicians and home health agencies. By delivering care directly to patients in their homes or workplaces, DispatchHealth aims to enhance the capabilities of existing care teams while providing high-quality, cost-effective healthcare solutions.

Octave

Series B in 2020
Octave is a clinical platform developer focused on transforming the care landscape for multiple sclerosis and other neurodegenerative diseases. The company creates a platform that generates, analyzes, and integrates data to improve patient outcomes and reduce overall healthcare costs. By optimizing medication usage and healthcare services, Octave aims to enhance the efficiency of the pharmaceutical industry throughout the entire lifecycle of drug development, which includes discovery, clinical trials, and post-marketing phases. Their approach utilizes real-world evidence to inform decision-making, ultimately striving to set a new standard in multiple sclerosis care.

Upfront Healthcare Services

Series B in 2020
Upfront Healthcare Services, Inc. is a Chicago-based company that specializes in creating a data analytics platform aimed at enhancing the ambulatory care experience for patients and healthcare providers. Founded in 2015, the company focuses on automating and personalizing care navigation to improve patient engagement and optimize resource allocation within physician practices. Its platform, known as Care Traffic Control, utilizes advanced analytics and personalized content to guide patients to the most appropriate care options, thereby increasing appointment efficiency and improving clinical outcomes. By leveraging a variety of data sources—including demographics, billing, scheduling, claims, and care gaps—Upfront Healthcare Services ensures that patient needs are effectively matched with available healthcare resources.

mPulse Mobile

Series C in 2020
mPulse Mobile, Inc. is a healthcare technology company based in Encino, California, specializing in communication solutions designed to enhance consumer health and wellness. The company offers mPulse, a cloud-based intelligent mobile messaging platform that features pre-configured workflows to address various healthcare challenges, including missed appointments, medication adherence, and disease management. Their solutions encompass a wide range of areas such as medication adherence, preventive care and screenings, chronic condition management, and optimization of health plan experiences. By leveraging conversational AI and analytics, mPulse Mobile aims to empower healthcare organizations to engage effectively with their customers, encouraging the adoption of healthier behaviors. Founded in 2014, the company serves diverse sectors, including Medicare, Medicaid, commercial plans, health systems, and wellness initiatives.

Cityblock

Series B in 2020
Cityblock Health, Inc., established in 2017 and headquartered in Brooklyn, New York, operates a personalized health system tailored to meet the unmet health and social needs of Medicaid and Medicare populations. The company's online platform offers integrated primary care, behavioral health, and virtual care services, along with a tool called Commons for communication, information sharing, and task management. Cityblock's model focuses on upstream investment in highly personalized, prevention-oriented care, aiming to improve outcomes and reduce costs. It partners with community-based organizations to deliver care, enabling clinicians to provide personalized care for each member. During the COVID-19 pandemic, Cityblock developed a model to help identify high-risk members within organizations.

DispatchHealth

Series C in 2020
DispatchHealth Management, LLC is a provider of on-demand mobile and virtual healthcare services, founded in 2013 and headquartered in Denver, Colorado. The company offers a wide range of services, including evaluation and treatment for acute injuries and illnesses, laceration repair, splinting of injured extremities, and management of conditions like nosebleeds and catheter placements. It also facilitates medication administration, laboratory testing, outpatient imaging arrangements, and coordination with primary care physicians and home health agencies. By delivering care directly to patients in their homes or workplaces, DispatchHealth aims to enhance the capabilities of existing care teams while providing high-quality, cost-effective healthcare solutions.

Abacus Insights

Series B in 2020
Abacus Insights, established in 2017 with headquarters in New York City and an additional office in Boston, specializes in developing a cloud-based data integration platform tailored for healthcare companies. This platform organizes and exchanges data from diverse sources and formats, offering maintenance and support services to clients. By standardizing data across the healthcare ecosystem through a secure unified infrastructure, Abacus Insights enables healthcare providers to generate actionable insights, enhance member outcomes, and lower care costs.

Amwell

Series C in 2020
Amwell is a telehealth platform based in the United States that facilitates the digital delivery of healthcare services. Founded in 2006 and headquartered in Boston, the company connects providers, insurers, patients, and innovators to enhance access to affordable, high-quality care. Amwell offers a comprehensive platform designed to address a wide range of telehealth needs, including urgent, acute, and post-acute care, as well as chronic care management and healthy living. With extensive experience in the field, Amwell supports over 240 health systems, which encompass 2,000 hospitals, and collaborates with 55 health plan partners, reaching more than 150 million individuals through over 36,000 employers. The platform provides both on-demand and scheduled consultations, enabling diverse care models that range from primary and urgent care to specialized services such as telestroke and telepsychiatry.

Aledade

Series C in 2020
Aledade is a health technology and services platform that partners with independent primary care physicians to form and operate Accountable Care Organizations in the United States. It provides data analytics, guided workflows, regulatory and contracting support, payer relationships, and local on-the-ground expertise to help practices transform operations, optimize care delivery, and align incentives around value-based care. The platform integrates care data across the continuum, offers practice management tools, and supports governance and policy guidance to enable autonomous physician groups—from small practices to multispecialty networks and community health centers—to improve patient outcomes while reducing overall costs. Headquartered in Bethesda, Maryland, the company was founded in 2014.

TytoCare

Venture Round in 2020
TytoCare develops handheld devices and software that enable users to perform self-examinations, facilitating remote diagnosis by healthcare professionals. The company's tools allow examination of various body areas and diagnose common conditions. TytoCare offers solutions for consumers (TytoHome), professionals (TytoPro), and remote clinics (TytoClinic). Incorporated in 2011, the company is headquartered in Netanya, Israel with an additional office in New York.

Aitia

Series D in 2019
Aitia is a leader in the application of Causal AI and Digital Twins focused on advancing drug discovery and development. The company utilizes machine learning and the convergence of multi-omic patient data to create Digital Twins that replicate the biological mechanisms of diseases. This innovative approach is particularly impactful in areas such as oncology, neurodegenerative disorders, and immunology. Aitia's Gemini Digital Twins are currently employed to identify novel therapies and expedite research and development in various conditions, including multiple myeloma, prostate cancer, Alzheimer’s Disease, Parkinson’s Disease, and Huntington’s Disease, with additional projects underway. The company collaborates with several prominent pharmaceutical firms, academic institutions, medical societies, and patient advocacy groups worldwide, thereby enhancing the potential for breakthroughs in medicine.

Genome Medical

Series B in 2019
Genome Medical operates a platform that connects individuals and healthcare providers with genetic specialists. It offers virtual genetic care services, including clinical consultations for various health areas like cancer, cardiology, and reproductive health. The company uses its Genome Care Delivery technology to facilitate efficient genetic assessments and personalized treatment plans.

Abacus Insights

Series A in 2019
Abacus Insights, established in 2017 with headquarters in New York City and an additional office in Boston, specializes in developing a cloud-based data integration platform tailored for healthcare companies. This platform organizes and exchanges data from diverse sources and formats, offering maintenance and support services to clients. By standardizing data across the healthcare ecosystem through a secure unified infrastructure, Abacus Insights enables healthcare providers to generate actionable insights, enhance member outcomes, and lower care costs.

DispatchHealth

Series B in 2019
DispatchHealth Management, LLC is a provider of on-demand mobile and virtual healthcare services, founded in 2013 and headquartered in Denver, Colorado. The company offers a wide range of services, including evaluation and treatment for acute injuries and illnesses, laceration repair, splinting of injured extremities, and management of conditions like nosebleeds and catheter placements. It also facilitates medication administration, laboratory testing, outpatient imaging arrangements, and coordination with primary care physicians and home health agencies. By delivering care directly to patients in their homes or workplaces, DispatchHealth aims to enhance the capabilities of existing care teams while providing high-quality, cost-effective healthcare solutions.

Cityblock

Series B in 2019
Cityblock Health, Inc., established in 2017 and headquartered in Brooklyn, New York, operates a personalized health system tailored to meet the unmet health and social needs of Medicaid and Medicare populations. The company's online platform offers integrated primary care, behavioral health, and virtual care services, along with a tool called Commons for communication, information sharing, and task management. Cityblock's model focuses on upstream investment in highly personalized, prevention-oriented care, aiming to improve outcomes and reduce costs. It partners with community-based organizations to deliver care, enabling clinicians to provide personalized care for each member. During the COVID-19 pandemic, Cityblock developed a model to help identify high-risk members within organizations.

Strive Health

Seed Round in 2019
Strive Health, LLC is a company focused on providing comprehensive solutions for chronic kidney disease. Founded in 2018 and based in Denver, Colorado, Strive Health operates dialysis centers and employs advanced predictive analytics to enhance patient care. The company offers a high-touch, technology-enabled clinical model that supports patients throughout their healthcare journey, from primary care engagement to dialysis treatment. By utilizing comparative and predictive data, Strive Health aims to identify at-risk patients and transform the management of kidney disease, promoting earlier intervention and increasing the adoption of home dialysis. This innovative approach not only improves patient outcomes but also seeks to reduce inpatient utilization, ultimately enhancing the overall experience for individuals dealing with chronic kidney conditions.

Aledade

Corporate Round in 2019
Aledade is a health technology and services platform that partners with independent primary care physicians to form and operate Accountable Care Organizations in the United States. It provides data analytics, guided workflows, regulatory and contracting support, payer relationships, and local on-the-ground expertise to help practices transform operations, optimize care delivery, and align incentives around value-based care. The platform integrates care data across the continuum, offers practice management tools, and supports governance and policy guidance to enable autonomous physician groups—from small practices to multispecialty networks and community health centers—to improve patient outcomes while reducing overall costs. Headquartered in Bethesda, Maryland, the company was founded in 2014.

Octave

Series A in 2018
Octave is a clinical platform developer focused on transforming the care landscape for multiple sclerosis and other neurodegenerative diseases. The company creates a platform that generates, analyzes, and integrates data to improve patient outcomes and reduce overall healthcare costs. By optimizing medication usage and healthcare services, Octave aims to enhance the efficiency of the pharmaceutical industry throughout the entire lifecycle of drug development, which includes discovery, clinical trials, and post-marketing phases. Their approach utilizes real-world evidence to inform decision-making, ultimately striving to set a new standard in multiple sclerosis care.

AccessOne

Venture Round in 2018
AccessOne is a healthcare fintech company established in 2002 and based in Fort Mill, South Carolina. The company specializes in providing patient-centric payment tools designed to assist consumers in managing their healthcare costs while enhancing hospital reimbursement. AccessOne offers a range of low and no-interest payment options for various patient balance types, including high-deductible plans and financial assistance, ensuring that no patient is denied credit or negatively impacted in their credit reporting. The company’s financial engagement platform focuses on automation, digitization, and effective communication, seamlessly integrating with major health information systems to streamline processes and improve performance metrics for healthcare providers. By eliminating manual entry and facilitating better revenue capture, AccessOne supports hospitals and health systems in achieving optimal financial outcomes.

mPulse Mobile

Series B in 2018
mPulse Mobile, Inc. is a healthcare technology company based in Encino, California, specializing in communication solutions designed to enhance consumer health and wellness. The company offers mPulse, a cloud-based intelligent mobile messaging platform that features pre-configured workflows to address various healthcare challenges, including missed appointments, medication adherence, and disease management. Their solutions encompass a wide range of areas such as medication adherence, preventive care and screenings, chronic condition management, and optimization of health plan experiences. By leveraging conversational AI and analytics, mPulse Mobile aims to empower healthcare organizations to engage effectively with their customers, encouraging the adoption of healthier behaviors. Founded in 2014, the company serves diverse sectors, including Medicare, Medicaid, commercial plans, health systems, and wellness initiatives.

Livongo

Series E in 2018
Livongo Health, Inc. is a consumer digital health company that specializes in providing an integrated suite of solutions for individuals managing chronic conditions, particularly diabetes. Established in 2008 and headquartered in Mountain View, California, Livongo utilizes real-time data capture and analytics to promote health behavior change through its platform, which includes cellular-connected devices, supplies, coaching, and insights driven by data science. Its product offerings encompass Livongo for diabetes, hypertension, prediabetes and weight management, and behavioral health through its myStrength platform. The company serves a diverse client base, including employers, health plans, government entities, and labor unions, primarily within the United States. Livongo aims to enhance the experience of individuals with chronic conditions by providing timely, personalized support and information, ultimately leading to improved health outcomes. In 2020, Livongo became a subsidiary of Teladoc Health, Inc.

Wildflower Health

Series C in 2018
Founded in 2012, Wildflower Health is a San Francisco-based company that specializes in smartphone-based health programs. It offers Due Date Plus for maternity care and GROW for family health, providing services such as reminders, provider look-up, and health risk assessments to support users and connect them with healthcare providers.

Springbuk

Series B in 2018
Springbuk, Inc. is an employer health analytics platform based in Indianapolis, Indiana, founded in 2015. The company offers a cloud-based health intelligence software that integrates various data sources, including medical claims, pharmacy, biometric, payroll, and activity data. This comprehensive platform enables employers to assess employee health and wellness, forecast healthcare spending, and evaluate the effectiveness of wellness programs. Through its predictive modeling engine, Springbuk allows employers to identify at-risk employees and tailor their engagement strategies accordingly. The company's focus is on utilizing data to enhance health outcomes and manage healthcare costs effectively.

Circulation

Series A in 2017
Circulation, Inc. is a Boston-based company founded in 2016 that offers a digital platform designed to enhance healthcare logistics by utilizing the Uber driver network for patient transportation. As a preferred partner of Uber in the healthcare sector, Circulation provides a customizable solution for coordinating non-emergency transportation to medical appointments and clinical trials. The platform is designed to improve efficiency and outcomes across the U.S. healthcare system, serving a range of users including patients, caregivers, providers, and volunteers. It ensures compliance with the Health Insurance Portability and Accountability Act (HIPAA), safeguarding the privacy and security of users' data. Circulation's technology integrates seamlessly with Uber’s API and other ride providers, streamlining the transportation process in healthcare settings.

Upfront Healthcare Services

Series A in 2017
Upfront Healthcare Services, Inc. is a Chicago-based company that specializes in creating a data analytics platform aimed at enhancing the ambulatory care experience for patients and healthcare providers. Founded in 2015, the company focuses on automating and personalizing care navigation to improve patient engagement and optimize resource allocation within physician practices. Its platform, known as Care Traffic Control, utilizes advanced analytics and personalized content to guide patients to the most appropriate care options, thereby increasing appointment efficiency and improving clinical outcomes. By leveraging a variety of data sources—including demographics, billing, scheduling, claims, and care gaps—Upfront Healthcare Services ensures that patient needs are effectively matched with available healthcare resources.

Phreesia

Series B in 2007
Phreesia is a privately held company that provides innovative software solutions aimed at enhancing patient check-in and engagement in healthcare settings. By replacing traditional patient clipboards with a wireless touchscreen device known as the PhreesiaPad, the company automates the check-in process, securely collecting personal health information in compliance with HIPAA regulations. This technology integrates seamlessly with existing electronic medical records, ensuring that physician workflows are not disrupted while capturing comprehensive patient data. Phreesia also improves the patient experience by facilitating appointment preparation, offering relevant health education, and enabling patients to verify previously recorded information. Additionally, the company focuses on activating patients in their care to optimize health outcomes through a range of services, including registration, appointment scheduling, payment processing, and post-appointment surveys. Backed by premier venture capital firms, Phreesia has raised significant funding to support its mission of enhancing the operational and financial performance of healthcare organizations.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.